Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies
Clinical trial NCT04648930 · COMPLETED
Trial details
- NCT number
- NCT04648930
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-27
- Primary completion
- 2022-11-03
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.